Has 5-Amino-1MQ been studied in humans
Engineered solely for preclinical investigations, each batch of AHK-Cu receives a comprehensive quality assessment and includes complete documentation, such as a Certificate of Analysis (COA), purity data, and structural verification
Safety Across Different Populations The clinical trial program predominantly enrolled individuals with clinical obesity, providing safety data specifically in this population
Combined Approaches (Neelakantan et al., 2022): NNMT inhibition with reduced-calorie diet produced dramatic adiposity reduction in DIO mice, normalizing metabolic parameters and establishing a distinct gut microbiome
Disguised Alpha Research Profile 5-Amino-1MQ is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency